Jingcui Peng

发表

Efficacy and Safety of Gefitinib Plus Anlotinib for Patients with EGFR Positive Advanced Non-Small-Cell Lung Cancer: A Retrospective Exploratory Study

Wenxia Hu, N. Geng, Jingcui Peng, 2022, International journal of general medicine.

The downregulation of miR-145 in A549 cells reduced lactate dehydrogenase (LDH) expression, apoptosis, caspase-3/-9 levels and Bax protein expression, while it increased cell proliferation. Upregulation of miR-145 in A459 cells increased LDH, apoptosis, caspase-3/-9 levels and Bax protein expression

C. Ding, Li Bin, W. Qin, 2018 .

MicroRNA‑145 inhibits migration and induces apoptosis in human non‑small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway.

C. Ding, W. Qin, N. Geng, 2018, Oncology reports.

A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer.

Zhanjun Guo, C. Ding, Shengmian Li, 2012, Experimental and therapeutic medicine.

Lung infection caused by Blastoschizomyces capitatus without immunodeficiency: a case report and review of the literature.

C. Ding, Jingcui Peng, Bin Li, 2022, Annals of palliative medicine.

Exosomes derived from M1 macrophages inhibit the proliferation of the A549 and H1299 lung cancer cell lines via the miRNA-let-7b-5p-GNG5 axis

C. Ding, Wenxia Hu, Jingcui Peng, 2023, PeerJ.

Clinical observation of crizotinib in the treatment of ALK-positive advanced non-small cell lung cancer.

Yueping Liu, H. Deng, C. Ding, 2019, Pathology, research and practice.

Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.

C. Ding, W. Qin, N. Geng, 2018, Oncology reports.

Exosomes Secreted from Mesenchymal Stem Cells Carry miR-486-5p to Inhibit Cell Proliferation and the Epithelial-Mesenchymal Transition Process to Treat Human Lung Cancer by Down-Regulating MIER3

C. Ding, Wenxia Hu, Jingcui Peng, 2022, Journal of Biomedical Nanotechnology.

Detection of an EML4-ALK fusion mutation secondary to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) therapy for lung cancer: a case report.

P. H. Hopchev, Jingcui Peng, Wen-wen Qin, 2022, Annals of palliative medicine.

A polymorphism at the miR-502 binding site in the 3' untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer.

Zhanjun Guo, C. Ding, Shengmian Li, 2012, Experimental and therapeutic medicine.